7.64
price down icon2.05%   -0.16
pre-market  Vorhandelsmarkt:  7.74   0.10   +1.31%
loading
Schlusskurs vom Vortag:
$7.80
Offen:
$7.77
24-Stunden-Volumen:
22,094
Relative Volume:
0.31
Marktkapitalisierung:
$434.74M
Einnahmen:
$154.57M
Nettoeinkommen (Verlust:
$15.07M
KGV:
28.30
EPS:
0.27
Netto-Cashflow:
$10.92M
1W Leistung:
+1.06%
1M Leistung:
+6.11%
6M Leistung:
+1.46%
1J Leistung:
+29.93%
1-Tages-Spanne:
Value
$7.64
$7.78
1-Wochen-Bereich:
Value
$7.37
$7.82
52-Wochen-Spanne:
Value
$5.08
$9.155

Kamada Ltd Stock (KMDA) Company Profile

Name
Firmenname
Kamada Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
374
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
KMDA's Discussions on Twitter

Vergleichen Sie KMDA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
KMDA
Kamada Ltd
7.64 434.74M 154.57M 15.07M 10.92M 0.27
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.89 13.23B 2.99B 1.21B 1.13B 25.06

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-21 Eingeleitet The Benchmark Company Buy
2024-07-03 Eingeleitet Stifel Buy
2018-02-02 Eingeleitet Chardan Capital Markets Buy

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

pulisher
01:34 AM

What analysts say about Kamada Ltd. stockExceptional growth trajectory - jammulinksnews.com

01:34 AM
pulisher
Jul 22, 2025

Is Kamada Ltd. a good long term investmentBreakthrough capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Kamada Ltd. stock price move sharplyHigh Potential Safe Trades - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Kamada Ltd. stock priceConsistent high-performance stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Kamada Ltd. Stock Analysis and ForecastOutstanding yields - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Kamada Ltd. stock attracts strong analyst attentionFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Kamada Ltd. stock performs during market volatilityProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

Emphysema Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Kamada, Ltd., Hoffmann-La Roche, Aeris Therapeutics, Grifols Therapeutics, Sanofi - MenaFN

Jul 15, 2025
pulisher
Jul 04, 2025

Is Kamada (KMDA) Stock Undervalued Right Now? - Nasdaq

Jul 04, 2025
pulisher
Jun 20, 2025

Kamada confirms continuous business operations despite recent events in Middle East - MSN

Jun 20, 2025
pulisher
Jun 18, 2025

Should Value Investors Buy Kamada (KMDA) Stock? - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Kamada Confirms Continuous Global Business Operations and - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada Ensures Global Operations Amid Middle East Tensions - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada confirms continuous business operations despite Middle East events - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Kamada Confirms No Supply Disruptions: How Israeli Biotech Giant Safeguards Global Product Availability - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

Plasma Therapeutics Market Revenue to Attain USD 46.46 Bn by 2033 - Precedence Research

Jun 17, 2025
pulisher
Jun 11, 2025

Kamada Reports Strong Q1 2025 Growth with Plasma Business Expansion and Key Milestones - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Implied Volatility Surging for Kamada Stock Options - Yahoo Finance

Jun 10, 2025
pulisher
Jun 07, 2025

Kamada Intensifies Efforts to Highlight CYTOGAM's Role in Combatting CMV in Organ Transplant Patients - citybuzz -

Jun 07, 2025
pulisher
Jun 06, 2025

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM - FinancialContent

Jun 06, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Sells 36,872 Shares of Kamada Ltd. (NASDAQ:KMDA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Are Investors Undervaluing Kamada (KMDA) Right Now? - Yahoo Finance

Jun 02, 2025
pulisher
May 27, 2025

Alpha-1 Antitrypsin Deficiency Market: Epidemiology, - openPR.com

May 27, 2025
pulisher
May 27, 2025

Kamada (NASDAQ:KMDA) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World

May 27, 2025
pulisher
May 23, 2025

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 23, 2025
pulisher
May 22, 2025

Kamada's (TLV:KMDA) Solid Earnings Are Supported By Other Strong Factors - simplywall.st

May 22, 2025
pulisher
May 19, 2025

Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm - The Manila Times

May 19, 2025
pulisher
May 19, 2025

HC Wainwright Issues Optimistic Outlook for Kamada Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Sidoti Csr Has Optimistic Outlook of Kamada FY2025 Earnings - Defense World

May 18, 2025
pulisher
May 18, 2025

Kamada’s (KMDA) Buy Rating Reiterated at Benchmark - Defense World

May 18, 2025
pulisher
May 16, 2025

Kamada Ltd. (NASDAQ:KMDA) Q1 2025 Earnings Call Transcript - MSN

May 16, 2025

Finanzdaten der Kamada Ltd-Aktie (KMDA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.34
price up icon 1.09%
$14.93
price up icon 1.70%
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
$132.75
price up icon 0.70%
$297.89
price up icon 1.63%
Kapitalisierung:     |  Volumen (24h):